PANCREAZE 10,500 UNT / 43,750 UNT / 25,000 UNT Delayed Release Oral Capsule
RxNorm 968915
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 968915 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PANCREAZE 10,500 UNT / 43,750 UNT / 25,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 43750 UNT / lipase 10500 UNT / protease 25000 UNT Delayed Release Oral Capsule [Pancreaze]
(Atom ID: 12371774)
SY
Synonym (SY):
Pancreaze 10 (amylase 43,750 UNT / lipase 10,500 UNT / proteases 25,000 UNT) Delayed Release Oral Capsule
(Atom ID: 6339461)
PSN